Tumor Lysis Syndrome in a Child with Osteosarcoma / 임상소아혈액종양
Clinical Pediatric Hematology-Oncology
;
: 75-79, 2011.
Artículo
en Coreano
| WPRIM
| ID: wpr-170950
ABSTRACT
Tumor lysis syndrome (TLS) is a metabolic derangement that may be seen after the initial treatment of cancer and usually occurs in patients with bulky, rapidly proliferating, or treatment-responsive tumors such as acute leukemia or Burkitt lymphoma. However, it is rare in the treatment of the solid tumor, especially osteosarcoma. An 11-year-old girl was admitted with a 3-months history of severe right leg pain. She was diagnosed as osteosarcoma and was treated with cisplatin and adriamycin. Three days after treatment, the values of potassium, phosphorus, uric acid were 6.4 mEq/L, 5.6 mg/dL and 8.9 mg/dL, respectively. At the same time, the value of calcium was 6.2 mg/dL. Although she was treated with proper conservative treatment including dialysis, she had significant complications such as renal failure, heart failure, hypoxic brain damage. We report a case of TLS in a girl with huge osteosarcoma.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Fósforo
/
Potasio
/
Ácido Úrico
/
Síndrome de Lisis Tumoral
/
Leucemia
/
Doxorrubicina
/
Osteosarcoma
/
Hipoxia Encefálica
/
Calcio
/
Linfoma de Burkitt
Límite:
Niño
/
Humanos
Idioma:
Coreano
Revista:
Clinical Pediatric Hematology-Oncology
Año:
2011
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS